Other Body1 KnowCo's: Empower your Life™
Back1 Body1 Dental1 Diabetes1 Fibroids1 Knee1 MedTech1 Reflux1 Shoulder1 Uterus1 Veins1 Wounds1
Body1
 Register
 Login
 Main Page
 Heart News
Feature Story
 Education Center
Conditions
Procedures
Diagnostics
 Heart Attack Center
Prevention
Survivors
Dr. Juerg Schmidli  Heart
 Hero™

Dr. Juerg Schmidli:
Revolutionizing Blood Pressure Care.
About Heroes
 Join the Discussion  in  Our Forums
 Community
Heart1 Forums
Patient Stories
 Reference
Online Resources
Video Library
advertisement
advertisement
Search the Body1 Network
   
October 07, 2008  
HEART NEWS: Feature Story

  • Print this Article
  • Email this Article
  • Links/Reprints
  • Investigators Question Ephedra Complaints

    Investigators Question Ephedra Complaints


    April 30, 2003

    WASHINGTON (AP) - Some 16,000 customer complaints about the popular Metabolife brand of ephedra are not enough to prove whether the herb caused dozens of heart attacks and strokes, some fatal, congressional investigators say.

    The report released Wednesday doesn't mean ephedra is safe, the Food and Drug Administration stressed: There is evidence from other sources that the pills can cause serious health problems.

    Armed with reports of more than 100 deaths and thousands of side effects linked to ephedra use, the FDA two months ago pledged to put warning labels on every bottle that say the amphetamine-like stimulant can cause heart attacks, strokes or even kill.

    The General Accounting Office, Congress' investigative arm, examined 16,000 records of phone calls from ephedra customers with health complaints turned over to the Justice Department last year by Metabolife International.

    The GAO counted 92 reports of serious side effects - including 18 heart attacks, 26 strokes, 43 seizures and five deaths - made by Metabolife customers to a company hot line.

    The GAO concluded that there was far too little information to definitively link any of the reports to the pills because patients, not doctors, reported the problems, and Metabolife employees sometimes recorded just a single word from each phone call.

    The FDA noted that the Rand Corp. also reviewed Metabolife's records, and called some of the cases "sentinel events" that warrant further investigation. Also, most of the agency's evidence is from other sources compiled before Metabolife revealed its records.

    "Today's report does nothing to change FDA's heightened concern that dietary supplements containing ephedra may present a significant and unreasonable risk of illness and injury," the agency said.

    Metabolife insisted the GAO report supports its position "that ephedrine-containing products such as Metabolife 356 are safe and effective when used as directed."

    Rep. Dan Burton, R-Ind., who requested the report, said the GAO's findings show the government needs to establish a federal tracking system for consumer complaints about any dietary supplement.

    The FDA decision came just weeks after Baltimore Orioles pitcher Steve Bechler died after using ephedra. Health and Human Services Secretary Tommy Thompson has advised Americans, especially those who exercise, not to take the herb.

    The American Heart Association and other health groups have urged a full ban on ephedra sales, calls the FDA currently is evaluating.


    Last updated: 30-Apr-03

    Comments

  • Add Comment
  •    
    Interact on Heart1

    Discuss this topic with others.
     
    Feature Archives

    Bone Marrow for Broken Hearts

    The Silent Destroyer – Part Four

    Diabetes and Joint Surgery Increases Heart Risk

    The Silent Destroyer: Part Three

    Screening For Abdominal Aortic Aneurysm

    Next 5 Features ...

    More Features ...
       
     
    Related Multimedia

    Plags/fatty deposits as a cause for a heart attack

    The risk of cardiac death due to a lower ejection fraction

    The function of a defibrillator

    More Features ...
     
    Related Content
    New Device Helps Reshape Damaged Hearts

    New Protein Predictor of Heart Failure

    U.S. to Ban Dietary Supplement Ephedra

    FDA About to Finalize Ephedra Ban

    Meditation Impacts Teen Blood Pressure

    More Features ...
     
    Home About Us Press Jobs Advertise With Us Contact Us
    advertisement
    ©1999- 2008 Body1, Inc. All rights reserved.
    Disclaimer: The information provided within this website is for educational purposes only and is not a substitute for consultation with your physician or healthcare provider. The opinions expressed herein are not necessarily those of the Owners and Sponsors of this site. By using this site you agree to indemnify, and hold the Owners and Sponsors harmless, from any disputes arising from content posted here-in.
    See our Terms of Service, our Privacy Policy, our Advertising Policy and our Editorial Policy.